Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
Details for Australian Patent Application No. 2004282491 (hide)
International Classifications
Event Publications
16 March 2006 PCT application entered the National Phase
PCT publication WO2005/037992 Priority application(s): WO2005/037992
19 June 2008 Alteration of Name
The name of the applicant has been altered to ImmunoGen, Inc. 2005
23 December 2010 Application Accepted
Published as AU-B-2004282491
3 March 2011 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 08 Feb 2011. Address for service in Australia - Griffith Hack Level 10 167 Eagle Street Brisbane QLD 4001 2005
30 June 2011 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 08 Feb 2011 2005
30 June 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004282492-Prevention of incorporation of nonstandard amino acids into protein
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser